The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Easofen Max Strength 400 mg Film-coated Tablets



Clonmel Healthcare LtdPA0126/060/002

Summary of Product Characteristics

« Back